The FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, but with restrictions. It's authorized for individuals 65 and ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...